R-Biopharm AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:R-Biopharm AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10468
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical diagnostics. It also provides food analysis test kits for the analysis of mycotoxins, antibiotics, hormones, genetically modified organisms, risk material, food allergens and microorganisms. R-Biopharm’s services include project management; development and validation of biomarker-based in-vitro diagnostic devices; validation and registration, manufacturing and commercialization. The company serves biotechnology and pharmaceutical industries. It has its presence in the UK, USA, Italy, France, Brazil, Spain, Australia and China. R-Biopharm is headquartered in Darmstadt, Germany.

R-Biopharm AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
R-Biopharm AG, Medical Equipment, Deal Details 10
Partnerships 10
ELITechGroup and R-Biopharm Enter into Agreement 10
R-Biopharm Enters into Agreement with Bosch Healthcare 11
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 12
R-Biopharm Enters into Agreement with HMNC Brain Health 13
R-Biopharm Enters into Agreement with Merck 14
Apogenix Enters into Agreement with R-Biopharm 15
R-Biopharm AG – Key Competitors 16
R-Biopharm AG – Key Employees 17
R-Biopharm AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
R-Biopharm AG, Medical Equipment, Key Facts 2
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Deals By Market, 2012 to YTD 2018 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ELITechGroup and R-Biopharm Enter into Agreement 10
R-Biopharm Enters into Agreement with Bosch Healthcare 11
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 12
R-Biopharm Enters into Agreement with HMNC Brain Health 13
R-Biopharm Enters into Agreement with Merck 14
Apogenix Enters into Agreement with R-Biopharm 15
R-Biopharm AG, Key Competitors 16
R-Biopharm AG, Key Employees 17
R-Biopharm AG, Subsidiaries 18

List of Figures
R-Biopharm AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[R-Biopharm AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Academy Sports + Outdoors:企業の戦略・SWOT・財務情報
    Academy Sports + Outdoors - Strategy, SWOT and Corporate Finance Report Summary Academy Sports + Outdoors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Esprit Holdings Limited:戦略・SWOT・企業財務分析
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sojitz Corporation (2768)-石油・ガス分野:企業M&A・提携分析
    Summary Sojitz Corporation (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • AMW GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …
  • China Petroleum & Chemical Corp (600028):電力:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Noble Corporation Plc (NE):石油・ガス:M&Aディール及び事業提携情報
    Summary Noble Corporation Plc (Noble) is an offshore drilling contractor for the oil and gas industry. It provides contract drilling services with its fleet of mobile offshore drilling units. The company’s offshore rig fleet operates in the global market and provides contract drilling services. Nobl …
  • Orica Ltd:企業の戦略・SWOT・財務情報
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Probi AB (PROB):企業の財務・戦略的SWOT分析
    Probi AB (PROB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Immune Design Corp (IMDZ):企業の財務・戦略的SWOT分析
    Summary Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company harnesses ZVex and GLAAS discovery platforms, to develop its product portfolio. Immune Design’s p …
  • United National Breweries (SA) (Pty) Limited:企業の戦略・SWOT・財務情報
    United National Breweries (SA) (Pty) Limited - Strategy, SWOT and Corporate Finance Report Summary United National Breweries (SA) (Pty) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • China Power Clean Energy Development Co Ltd (0735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Span Diagnostics Ltd (524727)-医療機器分野:企業M&A・提携分析
    Summary Span Diagnostics Ltd (SPAN) is a medical equipment company that develops and manufactures diagnostic products for healthcare markets. The company’s products include reagents, antibiotic disc and instruments. It offers reagents such as glucose, microprotein, amylase, calcium, chloride, uric a …
  • Advanced Micro Devices Inc (AMD):企業の財務・戦略的SWOT分析
    Advanced Micro Devices Inc (AMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Roper Technologies Inc (ROP):医療機器:M&Aディール及び事業提携情報
    Summary Roper Technologies Inc (Roper), formerly Roper Industries Inc, is a diversified technology company. It designs and develops software, and engineered products and solutions. It offers both software-as-a-service and licensed to customers. The company serves healthcare, water, food, transportat …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報
    Summary Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆